FOLH1 and prostate cancer: Retrospective studies have suggested a high sensitivity of PET using 68Ga-PSMA ligands in early restaging of prostate cancer but, as with other PET tracers, their value in primary tumour staging is yet to be determined, especially in patients with high-risk disease [30, 31].